In this study, we also show that a low dose of MMR can stimulate an immune response within the tumor, which, compared to control, is characterized by an increasing subset of CD8+ GranzymeB+ TILs and decreasing frequency of macrophage populations in murine HCC model. The gene discussed is CD8A; the disease is neoplasm.